Q4 2022 13F Holders as of 31 Dec 2022
-
Type / Class
-
Equity / *W EXP 12/31/202
-
Total 13F shares
-
638,163
-
Share change
-
-15,515
-
Total reported value
-
$98,934
-
Price per share
-
$0.16
-
Number of holders
-
8
-
Value change
-
-$4,400
-
Number of buys
-
3
-
Number of sells
-
1
Institutional Holders of EFFECTOR THERAPEUTICS INC - *W EXP 12/31/202 (EFTRW) as of Q4 2022
As of 31 Dec 2022,
EFFECTOR THERAPEUTICS INC - *W EXP 12/31/202 (EFTRW) was held by
8 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
638,163 shares.
The largest 8 holders included
WHITEBOX ADVISORS LLC, MMCAP International Inc. SPC, Parallel Advisors, LLC, Evolution Capital Management LLC, TENOR CAPITAL MANAGEMENT Co., L.P., CITADEL ADVISORS LLC, WOLVERINE ASSET MANAGEMENT LLC, and Jefferies Financial Group Inc..
This page lists
8
institutional shareholders reporting positions in this security
for the Q4 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.